Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Fuentes

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
International Journal of Molecular Sciences|December 10, 2021
Paradigmatic De Novo <i>GRIN1</i> Variants Recapitulate Pathophysiological Mechanisms Underlying GRIN1-Related Disorder Clinical SpectrumAna Santos-Gómez, Federico Miguez-Cabello, Natalia Juliá-Palacios, et al.
Plos Biology|September 10, 2024
The genetic basis of the kākāpō structural color polymorphism suggests balancing selection by an extinct apex predatorLara Urban, Anna W Santure, Lydia Uddstrom, et al.
European Journal of Immunology|May 2, 2022
ICAP-1 loss impairs CD8<sup>+</sup> thymocyte development and leads to reduced marginal zone B cells in miceSilvia Sevilla-Movilla, Patricia Fuentes, Yaiza Rodríguez-García, et al.
Molecular Oncology|December 14, 2020
Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemiaTra Ly Nguyen, Marie-Julie Nokin, Silvia Terés, et al.
Biomarker Research|October 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemiaCarlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, et al.
EMBO Molecular Medicine|June 5, 2025
Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1Ildefonso Sánchez-Cerrillo, María Agudo-Lera, Olga Popova, et al.
Cancer Immunology Research|April 1, 2022
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell EngagersBelén Blanco, Ángel Ramírez-Fernández, Clara Bueno, et al.
Frontiers in Cell and Developmental Biology|June 3, 2026
Correction: Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathyJuliana Ribeiro-Constante, Alba Tristán-Noguero, Fernando Francisco Martínez Calvo, et al.
Frontiers in Cell and Developmental Biology|March 20, 2024
Developmental outcome of electroencephalographic findings in <i>SYNGAP1</i> encephalopathyJuliana Ribeiro-Constante, Alba Tristán-Noguero, Fernando Francisco Martínez Calvo, et al.
Neurobiology of Disease|March 19, 2026
Genotype-phenotype correlations and putative modifier genes in SYNGAP1 encephalopathySelena Aranda, Juliana Ribeiro-Constante, Alba Tristán-Noguero, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
International Journal of Molecular Sciences|December 10, 2021
Paradigmatic De Novo <i>GRIN1</i> Variants Recapitulate Pathophysiological Mechanisms Underlying GRIN1-Related Disorder Clinical SpectrumAna Santos-Gómez, Federico Miguez-Cabello, Natalia Juliá-Palacios, et al.
Plos Biology|September 10, 2024
The genetic basis of the kākāpō structural color polymorphism suggests balancing selection by an extinct apex predatorLara Urban, Anna W Santure, Lydia Uddstrom, et al.
European Journal of Immunology|May 2, 2022
ICAP-1 loss impairs CD8<sup>+</sup> thymocyte development and leads to reduced marginal zone B cells in miceSilvia Sevilla-Movilla, Patricia Fuentes, Yaiza Rodríguez-García, et al.
Molecular Oncology|December 14, 2020
Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemiaTra Ly Nguyen, Marie-Julie Nokin, Silvia Terés, et al.
Biomarker Research|October 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemiaCarlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, et al.
EMBO Molecular Medicine|June 5, 2025
Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1Ildefonso Sánchez-Cerrillo, María Agudo-Lera, Olga Popova, et al.
Cancer Immunology Research|April 1, 2022
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell EngagersBelén Blanco, Ángel Ramírez-Fernández, Clara Bueno, et al.
Frontiers in Cell and Developmental Biology|June 3, 2026
Correction: Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathyJuliana Ribeiro-Constante, Alba Tristán-Noguero, Fernando Francisco Martínez Calvo, et al.
Frontiers in Cell and Developmental Biology|March 20, 2024
Developmental outcome of electroencephalographic findings in <i>SYNGAP1</i> encephalopathyJuliana Ribeiro-Constante, Alba Tristán-Noguero, Fernando Francisco Martínez Calvo, et al.
Neurobiology of Disease|March 19, 2026
Genotype-phenotype correlations and putative modifier genes in SYNGAP1 encephalopathySelena Aranda, Juliana Ribeiro-Constante, Alba Tristán-Noguero, et al.
Pageof 5